ALM vs NEM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ALM's deterministic health scores signal severe financial distress: the Piotroski F-Score of 1/9 indicates extreme weakness in operational and financial health, while the absence of an Altman Z-Score raises unquantified bankruptcy risk. Despite strong revenue growth (28% YoY) and a bullish analyst consensus (strong_buy), the company reports a negative profit margin (-216.27%), negative ROE (-57.31%), and negative earnings, rendering valuation metrics like Forward P/E (87.79) and Price/Book (31.95) meaningless. The stock trades at a massive premium to its fundamentals, with no intrinsic value or Graham Number available, suggesting speculative pricing. Insider activity is neutral, and the recent 20.2% one-week decline underscores high volatility and potential overvaluation.
NEM shows bullish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Key strengths include strong valuation and growth metrics. Price trades at a 155.7% premium to fair value estimate ($44.73), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
ALM vs NEM: Head-to-Head Comparison
This page compares Almonty Industries Inc. (ALM) and Newmont Corporation (NEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.